OptiBiotix Health PLC Launch of Slimbiome in Nutri-bites
08 March 2018 - 6:01PM
RNS Non-Regulatory
TIDMOPTI
OptiBiotix Health PLC
08 March 2018
OptiBiotix Health plc
("OptiBiotix" or the "Company")
Launch of Slimbiome(R) in Nutri-bites(R)
OptiBiotix Health plc (AIM:OPTI), a life sciences business
developing compounds to tackle obesity, and high cholesterol,
announces the launch of its award winning SlimBiome(R) in
Nutri-Bites(R) with its US partner, Cereal Ingredients ("CII"), at
the 2018 Natural Products Expo West & Engredea. The exhibition
is the world's largest trade show for organic, natural and healthy
products and typically attract more than 80,000 food and ingredient
buyers from around the world. OptiBiotix will join CII at stand
3788.
OptiBiotix has partnered with specialty ingredients manufacturer
CII Ingredients, to launch its patented weight management
technology, SlimBiome(R) in CII's Nutri-Bites(R) range of cereal
based food products. This extends SlimBiome(R) applications from
snack bars and shakes to breakfast cereals and bakery products
(e.g. cookies, cakes and tortillas) as well as increasing the range
of options for healthy snacks, yoghurts and cereal bars.
Products in the Nutri-Bites(R) range contain expanded cereal
pieces and are formulated with a choice of protein sizes and
content. These can be applied to granola and snack mix inclusions,
nutritional and cereal bars and coated snacks, or just used as a
healthy crunch topping.
This is a continuation of OptiBiotix's focus on the US market
following last years supply & manufacturing Aareement with CII,
announced on 12 December 2017. SlimBiome(R) is the first in a range
of products which helps to improve human health through the science
of the microbiome. Other products under development in the range
include ImmunoBiome, (R) CardioBiome(R) and WellBiome(R) .
Cereal Ingredients is a privately held speciality ingredients
manufacturer based in Kansas, USA, dedicated to the development,
manufacture and supply of unique, high-quality food ingredients
which contribute a meaningful point of difference.
Christina Wood, OptiBiotix Sales and Marketing Director, said:
"Many cereals and snack bars on the market are deceptively high in
sugar and calories, leading consumers with healthy intentions who
use these products to gain, rather than lose, weight. By combining
OptiBiotix's award winning SlimBiome(R) technology with CII's
market-leading ingredients manufacturing capacity and product
development, we have created a delicious functional solution which
can help customers manage their weight by reducing snacking and
food intake without food cravings. We are delighted to share this
innovative science based approach to weight management with food
and ingredient buyers from around the world at the Natural Products
Expo West & Engredea show."
For more information about Optibiotix, please visit
www.optibiotix.com
For further information, please contact:
OptiBiotix Health plc www.optibiotix.com
Stephen O'Hara, Chief Executive Contact via
Walbrook below
Walbrook PR Ltd Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy Mob: 07876 741
001
About OptiBiotix - www.optibiotix.com
OptiBiotix was formed in March 2012 to develop compounds which
modify the human microbiome - the collective genome of the microbes
in the body - to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial
strains, compounds and formulations, which modulate the human
microbiome and can be used as food ingredients and supplements or
active compounds for the prevention and management of human
metabolic diseases, examples of which include obesity, cholesterol
and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators
that can impact on lipid and cholesterol management, energy harvest
and appetite suppression. The development pipeline is fuelled by
its proprietary OptiScreen(R) and OptiBiotic(R) platform
technologies designed to identify metabolic pathways and compounds
that impact on human physiology and bring potential health
benefits.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAUBSARWSAORAR
(END) Dow Jones Newswires
March 08, 2018 02:01 ET (07:01 GMT)
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Apr 2024 to May 2024
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From May 2023 to May 2024